HIV-1 T-cell vaccines: evaluating the next step.
Giuseppe
G
Pantaleo
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D000256:Adenoviridae / Q000235:genetics / Q000276:immunology; D000914:Antibodies, Viral / Q000097:blood; D017322:Clinical Trials, Phase II as Topic; D005822:Genetic Vectors; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D054298:Human Immunodeficiency Virus Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology*; D017211:Treatment Failure; D019562:Viral Load
D016915:AIDS Vaccines; D000914:Antibodies, Viral; D054298:Human Immunodeficiency Virus Proteins